A61P 27 - Drugs for disorders of the senses

Patents for A61P 27 - Drugs for disorders of the senses (53,017)
11/2004
11/10/2004	EP1117408B9 Use of diltiazem for treating retinal pathologies
11/10/2004	CN1545509A Piperidine derivatives useful as modulators of chemokine receptor activity
11/10/2004	CN1545428A Treatment for ocular infections
11/10/2004	CN1545414A Organic compounds
11/10/2004	CN1544092A Ophthalmic compositions containing galactomannan polymers and borate
11/10/2004	CN1544075A Hypometropia treating and asthenopia relieving Chinese traditional medicine and its preparation
11/10/2004	CN1544074A Chinese traditional medicine for treating optical fundus hemorrhage and its preparing process
11/10/2004	CN1544072A Chinese traditional medicine for treating senile eye diseases and its preparation
11/10/2004	CN1544055A Oil of aromatic turmeric dripping pills and its preparing process
11/10/2004	CN1543952A Enoxacin ocular sustained release gelata and preparation thereof
11/10/2004	CN1174993C VEGI, an inhibitor for angiogenesis and tumor growth
11/10/2004	CN1174981C Imidazole [1,2-A] pyridine and pyrazole [2,3-a] pyridine derivatives
11/10/2004	CN1174978C Heterocyclic compound as inhibitors of rotamase enzymes
11/09/2004	US6815557 Tryptase inhibitors
11/09/2004	US6815534 Tissue plasminogen activator-like protease
11/09/2004	US6815465 Heterocyclic compounds inhibiting angiogenesis
11/09/2004	US6815463 For therapy of disease of cellular hyperproliferation in a subject
11/09/2004	US6815460 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors
11/09/2004	US6815451 1,2,3,4-Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists
11/09/2004	US6815441 Reaction products of taurultam and glucose
11/09/2004	US6815434 Administering otoprotectant glutathione peroxidase mimic (ebselen), xanthine oxidase inhibitor (allopurinol), and glutathione precursor (n-acetylcysteine)
11/09/2004	US6814985 Herbal compositions and uses for the treatment of allergic reactions
11/09/2004	US6814971 Comprising lecithin, oils, amphiphilic surfactant and an antigen; for protecting pig against a bordetella infections and/or a toxigenic pasteuralla infections
11/04/2004	WO2004095023A1 Novel method of screening
11/04/2004	WO2004094424A1 Nitrogen-containing heterocyclic compounds and use thereof
11/04/2004	WO2004093882A1 Remedies for diseases to be applied to eye
11/04/2004	WO2004093878A1 Use of fused pyridazine derivatives for treating dry eye disorders
11/04/2004	WO2004069232A3 Egfr tyrosine kinase inhibitor for treating cardiovascular dysfunction
11/04/2004	WO2004055154A3 Use of purine derivatives for inducing differentiation of supernumerary hair cells and deiters' cells in the developing organ of corti for treating deafness
11/04/2004	WO2004037167A3 Methods of treating dry eye disease with lantibiotics
11/04/2004	WO2003082867A8 Azaindolylpiperidine derivatives as antihistaminic and antiallergic agents
11/04/2004	US20040220403 For therapy and prophylaxis of Tachykinin-mediated diseases
11/04/2004	US20040220402 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
11/04/2004	US20040220244 PHOSPHOLIPASE INHIBITORS; use of inhibitor compositions in mammals to relieve sick conditions accompanied by enhanced PLA(2) activity such as inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease
11/04/2004	US20040220230 transfroming growth factor antagonist; therapy for urogenital disorders, cardiovascular disorders
11/04/2004	US20040220227 Remedies for allergic eye diseases
11/04/2004	US20040220204 mixture of fatty ester, alkylene carbonate, butylene glycol, diethylene glycol, monoalkyl ether and thickeners
11/04/2004	US20040220171 anticoagulants; immunomoderators; antiinflammatory agents
11/04/2004	US20040220145 Methods for treating hearing loss
11/04/2004	US20040220092 G-protein coupled receptors
11/04/2004	US20040220077 Therapy for neuropathic pain
11/04/2004	US20040219202 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety
11/04/2004	US20040219181 Sustained release drug delivery devices with coated drug cores
11/03/2004	EP1473003A2 Drug delivery device
11/03/2004	EP1472544A2 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
11/03/2004	EP1472514A2 Method of preparing delta-9 tetrahydrocannabinol
11/03/2004	EP1472377A2 Genetic polymorphisms in the preprotachykinin gene
11/03/2004	EP1472269A1 RNA INTERFERENCE MEDIATED INHIBITION OF INTERLEUKIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/03/2004	EP1472267A2 Rna interference mediated inhibition of protein tyrosine phosphatase type iva (prl3) gene expression using short interfering nucleic acid (sina)
11/03/2004	EP1472257A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
11/03/2004	EP1472247A1 Antimicrobial thiadiazinone derivatives useful in treatment of bacterial infections
11/03/2004	EP1472244A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
11/03/2004	EP1472243A1 Piperidine derivatives and their use as antagonists of tachykinins
11/03/2004	EP1472237A1 Catechol bioisosteres
11/03/2004	EP1472234A1 Quinazolinone derivatives and their use as cb agonists
11/03/2004	EP1472233A1 Pyrimidine compounds
11/03/2004	EP1472225A2 2-piperazine-pyridines useful for treating pain
11/03/2004	EP1472224A2 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
11/03/2004	EP1472221A2 Substituted indoles, method for production and use thereof for the inhibition of pain
11/03/2004	EP1472215A2 (oxime)carbamoyl fatty acid amide hydrolase inhibitors
11/03/2004	EP1472209A2 Lipoxin a4 analogs
11/03/2004	EP1471970A2 NOVEL MAMMALIAN MULTIPOTENT STEM CELLS AND COMPOSITIONS, METHODS OF PREPARATION AND METHODS OF ADMINISTRATION THEREOF
11/03/2004	EP1471933A1 Albumin-fused anti-angiogenesis peptides
11/03/2004	EP1471928A1 Hiv inhibiting proteins
11/03/2004	EP1471927A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
11/03/2004	EP1471926A2 Compositions and methods for the therapeutic use of an atonal-associated sequence
11/03/2004	EP1471925A2 Inorganic nanoparticles to modify the viscosity and physical properties of ophthalmic and otic compositions
11/03/2004	EP1471918A2 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
11/03/2004	EP1471915A2 2,4-pyrimidinediamine compounds and their uses
11/03/2004	EP1471902A1 Methods for treating hearing loss
11/03/2004	EP1471898A1 Lutein/zeaxanthin for glare protection
11/03/2004	EP1471884A1 Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier
11/03/2004	EP1471870A2 Use of lipid conjugates in the treatment of disease
11/03/2004	EP1383399B1 Nutritional supplement to treat macular degeneration
11/03/2004	EP1337271B1 Combination of gaba agonists and sorbitol dehydrogenase inhibitors
11/03/2004	EP1316559B1 Adenosine derivatives and use thereof
11/03/2004	EP1235814B1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS
11/03/2004	EP1232153B1 Imidazole derivatives and their use as raf kinase inhibitors
11/03/2004	EP1173177B1 Use of macrolide compounds for the treatment of dry eye
11/03/2004	EP1121929B1 Composition comprising di- and trisodiumsalts of echinochrome for treating ocular conditions
11/03/2004	EP1105371B1 Novel aryl sulphonamide amino acid esters and analogues
11/03/2004	EP0786994B1 Use of chloride channel blockers for reducing intraocular pressure
11/03/2004	CN1543456A Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
11/03/2004	CN1543358A Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity
11/03/2004	CN1543348A Hypotensive lipid and timolol compositions and methods of using same
11/03/2004	CN1543346A Novel compounds
11/03/2004	CN1543343A Preparation and diabetic use of gibberellins
11/03/2004	CN1542009A Preparation method and use of dipyridanmole derivative
11/03/2004	CN1542003A Preparation method and use of trimethoprim derivative
11/03/2004	CN1173948C Alpha-substituted arylsulphonamido hydroxamic acids as TNF-alpha and matrix metalloproteinase inhibitors
11/03/2004	CN1173702C Glucocorticoid containing pharmaceutical inhalant powder and method for sterilizing the powder
11/03/2004	CN1173697C Aniline disulfide derivatives for treating allergic diseases
11/02/2004	US6812364 Central nervous system disorders; psychological disorders; anticancer agents
11/02/2004	US6812253 4-Fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical
11/02/2004	US6812250 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
11/02/2004	US6812240 8-azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents
11/02/2004	US6812235 2-acylamino- beta -alanine derivatives and a pharmaceutically acceptable salt, useful as fibrinogen receptor antagonists
11/02/2004	US6812021 Isolated from streptococcus; for preparation of therapeutics (vaccines) to immunize against microbial infection; urinary tract infections; drug screening
11/02/2004	US6811779 Methods for reducing tumor growth with VEGF receptor antibody combined with radiation and chemotherapy
11/02/2004	CA2315614C Pyrazoles

1 ... 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 ... 531